About Xiel
Xiel is a company based in United Kingdom founded in 2019 was acquired by MIS Healthcare in February 2025. It operates as a Reseller / Distribution. Xiel offers products and services including Nuclear Medicine Solutions, Radiotherapy Solutions, and Diagnostic Imaging Solutions. Xiel operates in a competitive market with competitors including Cardinal Health, CNX Therapeutics, Concordia International, Bartec Technologies and SPL Pharma, among others.
- Headquarter Somerset, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Xiel Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
MIS Healthcare
(Feb 03, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Xiel
Xiel offers a comprehensive portfolio of products and services, including Nuclear Medicine Solutions, Radiotherapy Solutions, and Diagnostic Imaging Solutions.
Solutions for nuclear medicine are distributed to healthcare providers.
Radiotherapy solutions are provided to hospitals and clinics.
Diagnostic imaging products are supplied to medical facilities.
Funding Insights of Xiel
Detailed funding history for Xiel
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Xiel
Xiel has secured backing from 1 investor. Prominent investors backing the company include MIS Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Leading medical imaging solutions provider and service expert
|
Locked | Locked | Locked |
Investor details for Xiel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xiel
Investment portfolio details for Xiel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xiel
Detailed financials for Xiel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xiel Comparisons
Peer comparison for Xiel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xiel
Xiel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, CNX Therapeutics, Concordia International, Bartec Technologies and SPL Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Multiple healthcare products and services are provided to organizations.
|
|
| Locked | Locked | Locked |
Distributor of specialty drugs
|
|
| Locked | Locked | Locked |
Distributes specialty pharmaceutical drugs to healthcare providers.
|
|
| Locked | Locked | Locked |
Mediso: Advanced medical imaging systems and radioactive sources
|
|
| Locked | Locked | Locked |
International distribution of specialty medicines and pharmaceutical market access services.
|
Detailed competitors of Xiel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xiel
Complete news archive for Xiel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xiel
Xiel was founded in 2019.
Xiel is headquartered in United Kingdom. It is registered at Somerset, United Kingdom.
Xiel Limited is involved in the distribution of specialized medical technologies, focusing on nuclear medicine, radiotherapy, and diagnostic imaging solutions. The company operates in the UK and Ireland, partnering with global manufacturers to supply hospitals, universities, research institutes, and private companies. Their expertise lies in understanding the structure of UK healthcare systems, ensuring tailored solutions for nuclear medicine and radiotherapy departments. Innovative products are brought to market through a deep commitment to customer service and efficiency improvements.
Xiel's top competitors include Cardinal Health, CNX Therapeutics and Bartec Technologies.
Xiel offers Nuclear Medicine Solutions, Radiotherapy Solutions, and Diagnostic Imaging Solutions.
Xiel has 1 investor. Key investors include MIS Healthcare.